Genentech’s TH3RESA trial has many locations
 

This trial has 199 study locations, with over 50 locations in the U.S. The trial is for HER2+ metastatic survivors who have received at least two prior regimens of HER2-directed therapy. It has two arms: T-DM1 and treatment of physician’s choice. To read more about TH3RESA, visit http://clinicaltrials.gov/ct2/show/NCT01419197

For any patients, caregivers or doctors who are looking for available trials for T-DM1 or Pertuzumab, or if the TH3RESA trial is in a location on the list that’s not yet recruiting, please call Genentech’s Trial Information Support Line at 888-662-6728. The call line is staffed by trained nurses who can discuss available Genentech trials.